Resources from the same session
Welcome and introduction
Presenter: Josep Tabernero
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
Optimizing molecular approaches in HER2+ GI cancers
Presenter: Josep Tabernero
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
How a biomarker-driven approach is needed across lines of therapy in HER2+ Gastric/GEJ Cancer
Presenter: Sara Lonardi
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
Exploring new opportunities to improve outcomes in patients with HER2+ mCRC
Presenter: Zev Wainberg
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
The Evolution of HER2 positivity in the treatment of biliary tract cancers
Presenter: Zev Wainberg
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast
Safety considerations of HER2-directed therapy in GI cancers
Presenter: Sara Lonardi
Session: Daiichi Sankyo - Optimizing the treatment continuum with a molecular-based approach in HER2+ GI cancers
Resources:
Webcast